Home | Peptides Business Wire

Get all the latest Peptides Industry news delivered straight to your inbox

Sep 24, 2026

🧪Peptides and the boundary between supplements and drugs

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 17, 2026

Will lack of testing derail peptide therapy market? 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 10, 2026

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 3, 2026

🧪Gyms provide a pathway to peptides, but can they do it legally?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 27, 2026

Managing the practitioner-pharmacy relationship 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 20, 2026

🧪Lilly lashes out at peptide sellers but will regulators act?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 13, 2026

Longevity makes peptide therapy a "relationship" 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 6, 2026

How peptides are reshaping sports medicine 🧪

By Rick Polito, Peptides Business Wire editor

Edward Mandel, +1

🧪Peptides and the boundary between supplements and drugs

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 17, 2026

Will lack of testing derail peptide therapy market? 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 10, 2026

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Sep 3, 2026

🧪Gyms provide a pathway to peptides, but can they do it legally?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 27, 2026

Managing the practitioner-pharmacy relationship 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 20, 2026

🧪Lilly lashes out at peptide sellers but will regulators act?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 13, 2026

Longevity makes peptide therapy a "relationship" 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Aug 6, 2026

How peptides are reshaping sports medicine 🧪

By Rick Polito, Peptides Business Wire editor

Edward Mandel, +1

Get all the latest Peptides Industry news delivered straight to your inbox

🧪Peptides and the boundary between supplements and drugs

Will lack of testing derail peptide therapy market? 🧪

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

🧪Gyms provide a pathway to peptides, but can they do it legally?

Managing the practitioner-pharmacy relationship 🧪

🧪Lilly lashes out at peptide sellers but will regulators act?

Longevity makes peptide therapy a "relationship" 🧪

How peptides are reshaping sports medicine 🧪

Archive

🧪Peptides and the boundary between supplements and drugs

Will lack of testing derail peptide therapy market? 🧪

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

🧪Gyms provide a pathway to peptides, but can they do it legally?

Managing the practitioner-pharmacy relationship 🧪

🧪Lilly lashes out at peptide sellers but will regulators act?

Longevity makes peptide therapy a "relationship" 🧪

How peptides are reshaping sports medicine 🧪

Peptides Business Wire